Status:
COMPLETED
Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Stomatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Oral mucositis is a debilitating side effects of cancer treatment for which there is not much successful treatments at yet. The investigators are going to evaluate the effectiveness of topical morphin...
Eligibility Criteria
Inclusion
- Head and neck cancer patients
- Severe oral mucositis; grade III or IV of the World Health Organization (WHO) rating of global mucositis
- Willingness to participate
Exclusion
- History of severe renal or hepatic insufficiency
- Collagen-vascular disease
- Allergic reaction to morphine
- Current smokers or alcohol users
- Pregnant women
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01837446
Start Date
July 1 2011
End Date
October 1 2012
Last Update
April 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiation Oncology Department, Seyed Al-Shohada Hospital
Isfahan, Isfahan, Iran, 81849-17395